BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28463515)

  • 21. Aberrant DNA methylation-induced gene inactivation is associated with the diagnosis and/or therapy of T-cell leukemias.
    Kim SY; Shin DY; Kim SM; Lee M; Kim EJ
    Leuk Res; 2016 Aug; 47():116-22. PubMed ID: 27318093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.
    Robert MF; Morin S; Beaulieu N; Gauthier F; Chute IC; Barsalou A; MacLeod AR
    Nat Genet; 2003 Jan; 33(1):61-5. PubMed ID: 12496760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanaomycin A selectively inhibits DNMT3B and reactivates silenced tumor suppressor genes in human cancer cells.
    Kuck D; Caulfield T; Lyko F; Medina-Franco JL
    Mol Cancer Ther; 2010 Nov; 9(11):3015-23. PubMed ID: 20833755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and Characterization of Transition-State Analogue Inhibitors against Human DNA Methyltransferase 1.
    Lamiable-Oulaidi F; Harijan RK; Shaffer KJ; Crump DR; Sun Y; Du Q; Gulab SA; Khan AA; Luxenburger A; Woolhouse AD; Sidoli S; Tyler PC; Schramm VL
    J Med Chem; 2022 Apr; 65(7):5462-5494. PubMed ID: 35324190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticancer drug discovery targeting DNA hypermethylation.
    Yu N; Wang M
    Curr Med Chem; 2008; 15(14):1350-75. PubMed ID: 18537614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel class of selective non-nucleoside inhibitors of human DNA methyltransferase 3A.
    Huang S; Stillson NJ; Sandoval JE; Yung C; Reich NO
    Bioorg Med Chem Lett; 2021 May; 40():127908. PubMed ID: 33705897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of kazinol Q, a natural product from Formosan plants, as an inhibitor of DNA methyltransferase.
    Weng JR; Lai IL; Yang HC; Lin CN; Bai LY
    Phytother Res; 2014 Jan; 28(1):49-54. PubMed ID: 23447335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of murine DNA methyltransferase Dnmt3a by DNA duplexes containing pyrimidine-2(1H)-one.
    Cherepanova NA; Zhuze AL; Gromova ES
    Biochemistry (Mosc); 2010 Sep; 75(9):1115-25. PubMed ID: 21077830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A potent cell-active allosteric inhibitor of murine DNA cytosine C5 methyltransferase.
    Flynn J; Fang JY; Mikovits JA; Reich NO
    J Biol Chem; 2003 Mar; 278(10):8238-43. PubMed ID: 12477724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and synthesis of N-benzoyl amino acid derivatives as DNA methylation inhibitors.
    Garella D; Atlante S; Borretto E; Cocco M; Giorgis M; Costale A; Stevanato L; Miglio G; Cencioni C; Fernández-de Gortari E; Medina-Franco JL; Spallotta F; Gaetano C; Bertinaria M
    Chem Biol Drug Des; 2016 Nov; 88(5):664-676. PubMed ID: 27225604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA methylation and demethylation as targets for anticancer therapy.
    Szyf M
    Biochemistry (Mosc); 2005 May; 70(5):533-49. PubMed ID: 15948707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of novel 3-halo-3-nitroflavanones and their activities as DNA methyltransferase inhibitors in cancer cells.
    Pechalrieu D; Dauzonne D; Arimondo PB; Lopez M
    Eur J Med Chem; 2020 Jan; 186():111829. PubMed ID: 31757526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knockdown of DNMT1 and DNMT3a Promotes the Angiogenesis of Human Mesenchymal Stem Cells Leading to Arterial Specific Differentiation.
    Zhang R; Wang N; Zhang LN; Huang N; Song TF; Li ZZ; Li M; Luo XG; Zhou H; He HP; Zhang XY; Ma W; Zhang TC
    Stem Cells; 2016 May; 34(5):1273-83. PubMed ID: 26850336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural products as DNA methyltransferase inhibitors: a computer-aided discovery approach.
    Medina-Franco JL; López-Vallejo F; Kuck D; Lyko F
    Mol Divers; 2011 May; 15(2):293-304. PubMed ID: 20697809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of protein-protein interactions in allosteric drug design for DNA methyltransferases.
    Liang Z; Zhu Y; Liu X; Hu G
    Adv Protein Chem Struct Biol; 2020; 121():49-84. PubMed ID: 32312426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Function of DNA methyltransferase 3a in lead (Pb(2+) )-Induced Cyclooxygenase-2 gene.
    Tsai YT; Chang CM; Wang JY; Hou MF; Wang JM; Shiurba R; Chang WC; Chang WC
    Environ Toxicol; 2015 Sep; 30(9):1024-32. PubMed ID: 24639330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of DNA methyltransferase-1 instigates the expression of DNA methyltransferase-3a in angioplasty-induced restenosis.
    Boosani CS; Gunasekar P; Block M; Jiang W; Zhang Z; Radwan MM; Agrawal DK
    Can J Physiol Pharmacol; 2018 Oct; 96(10):1030-1039. PubMed ID: 30067080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-Aza-2'-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumor suppressor gene reactivation.
    Wozniak RJ; Klimecki WT; Lau SS; Feinstein Y; Futscher BW
    Oncogene; 2007 Jan; 26(1):77-90. PubMed ID: 16799634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA methyltransferase inhibitors-state of the art.
    Goffin J; Eisenhauer E
    Ann Oncol; 2002 Nov; 13(11):1699-716. PubMed ID: 12419742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA demethylating agents and chromatin-remodelling drugs: which, how and why?
    Villar-Garea A; Esteller M
    Curr Drug Metab; 2003 Feb; 4(1):11-31. PubMed ID: 12570743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.